The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 109.00
Bid: 107.00
Ask: 111.00
Change: 2.50 (2.35%)
Spread: 4.00 (3.738%)
Open: 106.50
High: 110.00
Low: 106.50
Prev. Close: 106.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Contracts

4 Dec 2008 07:00

RNS Number : 5128J
Intercede Group PLC
04 December 2008
 



4 December 2008

INTERCEDE GROUP plc

("Intercede" or "the Company")

New Contracts Relating to National Identity Programmes

Intercede (AIM: IGP), a leading producer of Identity and Credential Management Systems (IDCMS) software, announces that it has won two separate contracts to supply its MyID product and associated professional services in support of two national identity programmes.

The first contract is with a Middle East country. Once implemented, this system will support the issuance and life cycle management of national identity cards to the country's citizens.

The second contract is in support of an undisclosed government customer in a different country.

Under the terms of these contracts with local integrators in the respective countries, Intercede has received initial aggregate payments of $0.3m and purchase orders for a further $1m. An additional $0.5m of sales revenue is anticipated from these projects during Intercede's current financial year, with further revenues expected in future periods.

 "Intercede is pleased to have secured these important national identity card projects with strategically important nation states", said Richard Parris, Chairman and Chief Executive. "These awards demonstrate the scalability, security and international appropriateness of our solutions. Our expansion into the Middle East and into the wider national identity market provides Intercede with financial comfort and resilience at a time of macroeconomic uncertainty."

Further announcements will be made on both these projects when permission for disclosure has been granted by the government customers concerned.

About Intercede 

Intercede is the producer of the MyID™ Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, the Transportation Worker Identity Credential and two major US financial institutions. In Europe and the Middle East Intercede's MyID is being deployed in support of multiple government identity, health and corporate employee ID security projects.

For more details visit www.intercede.com

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Pelham Public Relations

Tel. +44 (0)20 7743 6679

Archie Berens

Robert Koh

KBC Peel Hunt

Tel. + 44 (0)20 7418 8900

Richard Kauffer

Daniel Harris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFKNKNOBDDPBK
Date   Source Headline
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.